IonMed Announces Successful Completion of the First European Cold Plasma Clinical Study for Closure of Surgical WoundsMay 8, 2013 9:01 am | by The Associated Press | News | Comments
Results from a 16 patient study led by Prof. Abrahamyan at the Republican Institute of Reproductive Health, Perinatology, Obstetrics and Gynecology in Yerevan, Armenia demonstrate the safety and effectiveness of IonMed's BioWeld1TM cold plasma system. BioWeld1 is the first cold-plasma...
Heart Rhythm 2013 - ScottCare Launches Innovations in Universal Management of Cardiac Implantable Electronic Device (CIED) DataMay 8, 2013 9:00 am | by The Associated Press | News | Comments
CLEVELAND--(BUSINESS WIRE)--May 8, 2013--As a technology leader in devices and software for cardiology diagnosis, therapy and rehabilitation, ScottCare will unveil new advances in importing, monitoring and reviewing CIED data at this year’s Heart Rhythm Society’s Scientific Session, Heart Rhythm...
St. Jude Medical Announces CE Mark Approval of Next-Generation Ellipse and SJM Assura High Voltage DevicesMay 8, 2013 8:00 am | by The Associated Press | News | Comments
ST. PAUL, Minn.--(BUSINESS WIRE)--May 8, 2013--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced CE Mark approval of its next-generation Ellipse™ and SJM Assura™ portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy...
Pluristem Carving Out Distinct Niche in Orthopedic Medicine With New Clinical Trials in Rotator Cuff RepairMay 8, 2013 7:03 am | by The Associated Press | News | Comments
Pluristem (NASDAQ: PSTI) recently announced a new Phase I trial to check safety and evaluate effectiveness of its PLX-PAD cells in chronic tendonitis often leading to rotator cuff disorders, common in tennis players and golfers, where there are roughly 200,000 rotator cuff surgeries done each...
Elixir Medical Announces FDA Approval to Commence EXCELLA III Clinical Trial with DESyne® Nx Novolimus Eluting Coronary Stent System in the United StatesMay 8, 2013 7:00 am | by The Associated Press | News | Comments
SUNNYVALE, Calif--(BUSINESS WIRE)--May 8, 2013--Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced today that it has received approval from the Food and Drug Administration (FDA) to initiate patient enrollment...
Demand for Hybrid Solutions to Spur European Interventional Radiology and Cardiology Markets, finds Frost & SullivanMay 8, 2013 4:00 am | by PR Newswire | News | Comments
LONDON, May 8, 2013 /PRNewswire/ -- The European market for interventional radiology and cardiology is heading towards maturity, especially in Western Europe. Although the economic slowdown and fewer orders had a negative impact on revenues in 2012, it is expected that expanding...
Meeting Announcement: June 13, 2013 Microbiology Devices Panel of the Medical Devices Advisory CommitteeMay 8, 2013 12:00 am | by U.S. Food & Drug Administration | News | Comments
The committee's discussion will involve making recommendations regarding regulatory classification to either confirm class I or reclassify these devices into class II with special controls. The committee will address issues such as device performance and public health impact to determine whether special controls are needed to ensure the safety and effectiveness of these tests through their total product life cycle.
LinkTech’s new Push-In Couplings are well suited for use on durable and disposable medical equipment. They offer the highest flow with no installation tooling needed. These space efficient couplings are designed and manufactured to eliminate leak points and costs, providing a trouble free connection with a long service life.
Dr. Eisuke Fukuma has treated 58 breast cancer patients with cryoablation over the last 6 years under a research protocol at Kameda Medical Center in Japan. As of today, none of the patients have had a tumor reoccur or distant metastases. By this non-surgical treatment, Dr. Fukuma's patients avoid the risks and potential cosmetic impact of major breast cancer surgery.
Leica Microsystems and TrueVision 3D Surgical announced the debut of 3D surgical microscopes at the 81st Annual Scientific Meeting of the American Association of Neurological Surgeons. By incorporating the digital smart 3D system inside select models, Leica Microsystems and TrueVision have eliminated the need for a separate 3D cart.
Stackpole’s RC series is an axial leaded carbon composition technology available in 1/4W, 1/2W, and 1W power ratings. The RC’s dense carbon slug element handles high-energy surges much better than metal film based surge resistors.
Available in 3 sizes and multiple gear ratios, Groschopp’s new i-series gearboxes are ideal for applications that have stringent space limitations yet require a high yield torque and increased efficiency. Available with AC, PMDC and Brushless motors, the i-series gearbox has been pre-engineered with a custom design interface to mate with Groschopp motors.
Critics of the new 2.3% medical device excise tax are hitting new heights with their claims of dire consequences. Conservative blogger and attorney Johnathan Emord blogged that the tax will "wipe out an entire industry," and further asserts that the tax is "one of the most draconian tax burdens in history." What are the facts? Is the industry overreacting?
In the study of human diseases and potential treatments, small animal models play a crucial role in bridging the gap between in vitro and in vivo studies. When considering imaging techniques for small animal studies, positron emission tomography (PET) is well suited to the measurement of highly specific molecular interactions (e.g., glucose uptake and target-receptor binding).
The Combat Ready Clamp made history Friday when it received new critical indications from the FDA making it the first device of its kind approved to treat unmanageable amputations and pelvic wounds not addressable with standard limb tourniquets.